Skip to main content
PMC home page
Journal of Bacteriology logoLink to Journal of Bacteriology
. 1995 Jun;177(11):2965–2970. doi: 10.1128/jb.177.11.2965-2970.1995

Characterization of the gene for the chromosomal dihydrofolate reductase (DHFR) of Staphylococcus epidermidis ATCC 14990: the origin of the trimethoprim-resistant S1 DHFR from Staphylococcus aureus?

G E Dale 1, C Broger 1, P G Hartman 1, H Langen 1, M G Page 1, R L Then 1, D Stüber 1
PMCID: PMC176980  PMID: 7768789

Abstract

The gene for the chromosomally encoded dihydrofolate reductase (DHFR) of Staphylococcus epidermidis ATCC 14990 has been cloned and characterized. The structural gene encodes a polypeptide of 161 amino acid residues with a calculated molecular weight of 18,417. This trimethoprim-sensitive (Tmps) DHFR, SeDHFR, differs in only three amino acids (Val-31-->Ile, Gly-43-->Ala, and Phe-98-->Tyr) from the trimethoprim-resistant (Tmpr) S1 DHFR encoded by transposon Tn4003. Since in addition the S. epidermidis gene also forms part of an operon with thyE and open reading frame 140 as in Tn4003, the chromosomally located gene encoding the Tmps SeDHFR is likely to be the molecular origin of the plasmid-located gene encoding the Tmpr S1 DHFR. Site-directed mutagenesis and kinetic analysis of the purified enzymes suggest that a single Phe-->Tyr change at position 98 is the major determinant of trimethoprim resistance.

Full Text

The Full Text of this article is available as a PDF (502.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams J. A., Fierke C. A., Benkovic S. J. The function of amino acid residues contacting the nicotinamide ring of NADPH in dihydrofolate reductase from Escherichia coli. Biochemistry. 1991 Nov 19;30(46):11046–11054. doi: 10.1021/bi00110a006. [DOI] [PubMed] [Google Scholar]
  2. Appleman J. R., Tsay J. T., Freisheim J. H., Blakley R. L. Effect of enzyme and ligand protonation on the binding of folates to recombinant human dihydrofolate reductase: implications for the evolution of eukaryotic enzyme efficiency. Biochemistry. 1992 Apr 14;31(14):3709–3715. doi: 10.1021/bi00129a021. [DOI] [PubMed] [Google Scholar]
  3. Baccanari D. P., Joyner S. S. Dihydrofolate reductase hysteresis and its effect of inhibitor binding analyses. Biochemistry. 1981 Mar 31;20(7):1710–1716. doi: 10.1021/bi00510a002. [DOI] [PubMed] [Google Scholar]
  4. Bennett P. M., Heritage J., Hawkey P. M. An ultra-rapid method for the study of antibiotic resistance plasmids. J Antimicrob Chemother. 1986 Sep;18(3):421–424. doi: 10.1093/jac/18.3.421. [DOI] [PubMed] [Google Scholar]
  5. Bernstein F. C., Koetzle T. F., Williams G. J., Meyer E. F., Jr, Brice M. D., Rodgers J. R., Kennard O., Shimanouchi T., Tasumi M. The Protein Data Bank. A computer-based archival file for macromolecular structures. Eur J Biochem. 1977 Nov 1;80(2):319–324. doi: 10.1111/j.1432-1033.1977.tb11885.x. [DOI] [PubMed] [Google Scholar]
  6. Bolin J. T., Filman D. J., Matthews D. A., Hamlin R. C., Kraut J. Crystal structures of Escherichia coli and Lactobacillus casei dihydrofolate reductase refined at 1.7 A resolution. I. General features and binding of methotrexate. J Biol Chem. 1982 Nov 25;257(22):13650–13662. [PubMed] [Google Scholar]
  7. Burdeska A., Ott M., Bannwarth W., Then R. L. Identical genes for trimethoprim-resistant dihydrofolate reductase from Staphylococcus aureus in Australia and central Europe. FEBS Lett. 1990 Jun 18;266(1-2):159–162. doi: 10.1016/0014-5793(90)81529-w. [DOI] [PubMed] [Google Scholar]
  8. Bystroff C., Oatley S. J., Kraut J. Crystal structures of Escherichia coli dihydrofolate reductase: the NADP+ holoenzyme and the folate.NADP+ ternary complex. Substrate binding and a model for the transition state. Biochemistry. 1990 Apr 3;29(13):3263–3277. doi: 10.1021/bi00465a018. [DOI] [PubMed] [Google Scholar]
  9. Church G. M., Gilbert W. Genomic sequencing. Proc Natl Acad Sci U S A. 1984 Apr;81(7):1991–1995. doi: 10.1073/pnas.81.7.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cohen M. L. Epidemiology of drug resistance: implications for a post-antimicrobial era. Science. 1992 Aug 21;257(5073):1050–1055. doi: 10.1126/science.257.5073.1050. [DOI] [PubMed] [Google Scholar]
  11. Coughter J. P., Johnston J. L., Archer G. L. Characterization of a staphylococcal trimethoprim resistance gene and its product. Antimicrob Agents Chemother. 1987 Jul;31(7):1027–1032. doi: 10.1128/aac.31.7.1027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Dale G. E., Broger C., Langen H., D'Arcy A., Stüber D. Improving protein solubility through rationally designed amino acid replacements: solubilization of the trimethoprim-resistant type S1 dihydrofolate reductase. Protein Eng. 1994 Jul;7(7):933–939. doi: 10.1093/protein/7.7.933. [DOI] [PubMed] [Google Scholar]
  13. Dale G. E., Schönfeld H. J., Langen H., Stieger M. Increased solubility of trimethoprim-resistant type S1 DHFR from Staphylococcus aureus in Escherichia coli cells overproducing the chaperonins GroEL and GroES. Protein Eng. 1994 Jul;7(7):925–931. doi: 10.1093/protein/7.7.925. [DOI] [PubMed] [Google Scholar]
  14. Dale G. E., Then R. L., Stüber D. Characterization of the gene for chromosomal trimethoprim-sensitive dihydrofolate reductase of Staphylococcus aureus ATCC 25923. Antimicrob Agents Chemother. 1993 Jul;37(7):1400–1405. doi: 10.1128/aac.37.7.1400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Dauber-Osguthorpe P., Roberts V. A., Osguthorpe D. J., Wolff J., Genest M., Hagler A. T. Structure and energetics of ligand binding to proteins: Escherichia coli dihydrofolate reductase-trimethoprim, a drug-receptor system. Proteins. 1988;4(1):31–47. doi: 10.1002/prot.340040106. [DOI] [PubMed] [Google Scholar]
  16. Devereux J., Haeberli P., Smithies O. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 1984 Jan 11;12(1 Pt 1):387–395. doi: 10.1093/nar/12.1part1.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Filman D. J., Bolin J. T., Matthews D. A., Kraut J. Crystal structures of Escherichia coli and Lactobacillus casei dihydrofolate reductase refined at 1.7 A resolution. II. Environment of bound NADPH and implications for catalysis. J Biol Chem. 1982 Nov 25;257(22):13663–13672. [PubMed] [Google Scholar]
  18. Iwakura M., Kawata M., Tsuda K., Tanaka T. Nucleotide sequence of the thymidylate synthase B and dihydrofolate reductase genes contained in one Bacillus subtilis operon. Gene. 1988 Apr 15;64(1):9–20. doi: 10.1016/0378-1119(88)90476-3. [DOI] [PubMed] [Google Scholar]
  19. Lee C. C., Wu X. W., Gibbs R. A., Cook R. G., Muzny D. M., Caskey C. T. Generation of cDNA probes directed by amino acid sequence: cloning of urate oxidase. Science. 1988 Mar 11;239(4845):1288–1291. doi: 10.1126/science.3344434. [DOI] [PubMed] [Google Scholar]
  20. Lyon B. R., Skurray R. Antimicrobial resistance of Staphylococcus aureus: genetic basis. Microbiol Rev. 1987 Mar;51(1):88–134. doi: 10.1128/mr.51.1.88-134.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Matthews D. A., Bolin J. T., Burridge J. M., Filman D. J., Volz K. W., Kaufman B. T., Beddell C. R., Champness J. N., Stammers D. K., Kraut J. Refined crystal structures of Escherichia coli and chicken liver dihydrofolate reductase containing bound trimethoprim. J Biol Chem. 1985 Jan 10;260(1):381–391. [PubMed] [Google Scholar]
  22. Matthews D. A., Bolin J. T., Burridge J. M., Filman D. J., Volz K. W., Kraut J. Dihydrofolate reductase. The stereochemistry of inhibitor selectivity. J Biol Chem. 1985 Jan 10;260(1):392–399. [PubMed] [Google Scholar]
  23. Mitraki A., Fane B., Haase-Pettingell C., Sturtevant J., King J. Global suppression of protein folding defects and inclusion body formation. Science. 1991 Jul 5;253(5015):54–58. doi: 10.1126/science.1648264. [DOI] [PubMed] [Google Scholar]
  24. Neu H. C. The crisis in antibiotic resistance. Science. 1992 Aug 21;257(5073):1064–1073. doi: 10.1126/science.257.5073.1064. [DOI] [PubMed] [Google Scholar]
  25. Oefner C., D'Arcy A., Winkler F. K. Crystal structure of human dihydrofolate reductase complexed with folate. Eur J Biochem. 1988 Jun 1;174(2):377–385. doi: 10.1111/j.1432-1033.1988.tb14108.x. [DOI] [PubMed] [Google Scholar]
  26. Rouch D. A., Messerotti L. J., Loo L. S., Jackson C. A., Skurray R. A. Trimethoprim resistance transposon Tn4003 from Staphylococcus aureus encodes genes for a dihydrofolate reductase and thymidylate synthetase flanked by three copies of IS257. Mol Microbiol. 1989 Feb;3(2):161–175. doi: 10.1111/j.1365-2958.1989.tb01805.x. [DOI] [PubMed] [Google Scholar]
  27. Sander C., Schneider R. Database of homology-derived protein structures and the structural meaning of sequence alignment. Proteins. 1991;9(1):56–68. doi: 10.1002/prot.340090107. [DOI] [PubMed] [Google Scholar]
  28. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Smith D. R., Calvo J. M. Nucleotide sequence of the E coli gene coding for dihydrofolate reductase. Nucleic Acids Res. 1980 May 24;8(10):2255–2274. doi: 10.1093/nar/8.10.2255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Southern E. M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975 Nov 5;98(3):503–517. doi: 10.1016/s0022-2836(75)80083-0. [DOI] [PubMed] [Google Scholar]
  31. Swartz M. N. Hospital-acquired infections: diseases with increasingly limited therapies. Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2420–2427. doi: 10.1073/pnas.91.7.2420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Wetzel R. Mutations and off-pathway aggregation of proteins. Trends Biotechnol. 1994 May;12(5):193–198. doi: 10.1016/0167-7799(94)90082-5. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Bacteriology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES